12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Tempest Therapeutics (NASDAQ:TPST) shares rose 32.8% to $3.79 during Thursday’s pre-market session. The company’s market cap stands…
SAB Biotherapeutics Rebrands as SAB BIO, Focuses on Type 1 Diabetes Therapies
SAB Biotherapeutics (NASDAQ:SABS) (the "Company" or "SAB"), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Nexalin Technology (NASDAQ:NXL) stock increased by 48.1% to $1.54 during Wednesday’s after-market session. The company’s market cap…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Nexalin Technology (NASDAQ:NXL) shares rose 55.8% to $1.62 during Tuesday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers OneMedNet (NASDAQ:ONMD) shares moved upwards by 118.4% to $1.07 during Thursday’s regular session. The market value of…
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Shares of Applied Therapeutics, Inc.
Cal-Maine Foods, UniFirst And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying
The Dow Jones closed higher by more than 500 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
EXCLUSIVE: SAB Biotherapeutics Kickstarts Phase 1 Study For Its Lead Type 1 Diabetes Hopeful In Australia
SAB Biotherapeutics Inc (NASDAQ: SABS) announced that the first HUMAN trial participants (Fully HUman anti-thymocyte biologic in a first-in-MAN clinical study) have been dosed in Australia.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers LumiraDx (NASDAQ:LMDX) shares rose 42.8% to $0.14 during Thursday’s regular session. LumiraDx’s stock is trading at a…